Top Line
Understanding and managing key longevity biomarkers, such as telomere length, epigenetic clocks, and inflammation levels, may help slow the aging process and enhance lifespan and health.
Why it Matters
Aging is inevitable, but slowing its biological effects can improve our quality of life. Biomarkers provide insights into our biological age versus chronological age, helping identify early signs of aging and the effectiveness of interventions. This knowledge allows for targeted lifestyle changes that can promote longevity, making it possible to live longer and healthier.
Key Takeaways
1. Biomarkers Defined: These biological measures assess health status and predict aging, allowing for personalized anti-aging strategies.
2. Key Biomarkers for Longevity:
- Telomere Length: Shorter telomeres indicate cellular aging and higher disease risk.
- Epigenetic Clocks: DNA methylation precisely measures biological age and potential interventions.
- Inflammatory Markers: Chronic inflammation drives aging; reducing inflammation is crucial for healthy aging.
- Metabolic Markers: Maintaining glucose, insulin, and lipid levels supports long-term health.
- Oxidative Stress Markers: Balancing oxidative stress with antioxidants is vital to longevity.
3. Lifestyle Factors:
- Optimizing biomarker health requires a balanced diet, regular exercise, stress management, and avoiding harmful substances.
- Supplements and medications like Vitamin D and metformin may further support healthy aging.
4. Future Directions: Aging research is rapidly evolving, with biotechnologies and personalized medicine poised to enhance health span and provide more targeted interventions.
Introduction
Aging is a natural process, but understanding its mechanics may enable us to slow it down. The concept of "biomarkers" has transformed aging research, allowing scientists to measure and understand the rate of biological aging versus chronological age. In this article, we’ll explore five essential biomarkers for longevity and how lifestyle changes can influence them, giving us tools to enhance our lifespan and, more importantly, our health span.
What are Biomarkers?
Biomarkers are biological measures that indicate an individual's health status. They can range from genetic markers to hormones, blood cells, and metabolic indicators, providing insights into biological age and health trajectory. By monitoring these markers, we can assess early signs of aging and the effectiveness of interventions to slow the aging process.
Key Biomarkers for Longevity
1. Telomere Length
Telomeres are the protective ends of chromosomes, and their length correlates with cellular aging. Each cell division shortens these telomeres, making them a strong indicator of aging. Stress, diet, and physical activity influence telomere length, affecting longevity and susceptibility to age-related diseases.
2. Epigenetic Clocks
Epigenetic clocks measure biological age based on DNA methylation. Methylation is a biochemical process in which a methyl group (CH₃) is added to DNA, proteins, or other molecules. In the context of DNA, this process typically occurs at cytosine bases, particularly in regions called CpG sites. Methylation can regulate gene expression, often silencing genes when methyl groups are added, which can have significant implications in development, cellular differentiation, and diseases like cancer. Methylation can also affect the structure and function of proteins, influencing various biological processes and, as a result, offering a more precise prediction of health span than chronological age. Clocks like the Horvath clock help scientists assess an individual’s biological age, providing an avenue to test anti-aging interventions.
3. Inflammatory Markers
Known as “inflammaging,” chronic inflammation is a significant driver of aging and related diseases. Markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and TNF-α reveal inflammation levels linked to cardiovascular disease and diabetes. Reducing inflammation is crucial for healthy aging.
- C-reactive protein (CRP): Optimal CRP levels are typically recommended to be below 1 mg/L. Levels between 1 and 3 mg/L indicate moderate risk, while levels above 3 mg/L are associated with higher inflammation and a greater risk of age-related diseases.1,2
- Interleukin-6 (IL-6): In healthy, low-inflammation states, IL-6 levels should ideally remain below 1 pg/mL. However, IL-6 levels can vary considerably, so maintaining levels closer to 1.0 pg/mL is associated with reduced risk for cardiovascular, metabolic, and neurodegenerative diseases.3
- Tumor Necrosis Factor-alpha (TNF-α): TNF-α levels should be around 1.5 pg/mL or lower. Elevated TNF-α levels are linked to chronic low-grade inflammation associated with insulin resistance, cardiovascular disease, and other aging-related conditions.4,5
4. Metabolic Markers
Metabolic health is closely linked to longevity, with markers like fasting glucose, insulin, and lipid levels offering insight into an individual's health. Metabolic disorders like diabetes and cardiovascular diseases are associated with accelerated aging, so maintaining metabolic health is vital for long-term wellness.
- The optimal fasting glucose range for the lowest mortality in adults with diabetes is approximately 90-130 mg/dL, with a lower range of 80-95 mg/dL for younger adults aged 18-44 years without diabetes.6
- There is no defined optimal fasting insulin level for promoting a longer health span. However, the current evidence considers it to be below 6 µU/mL, with some research suggesting an even lower range, around 2-5 µU/mL, as ideal for minimizing risks associated with insulin resistance, metabolic syndrome, and cardiovascular disease.
- For optimal longevity, adults should aim to maintain LDL-C levels around 74-130 mg/dL,7 HDL-C levels between 50-79 mg/dL,8 non-HDL-C levels below 130 mg/dL,9 and triglyceride levels above 147 mg/dL.7 These ranges are associated with lower all-cause and cardiovascular mortality.
5. Oxidative Stress Markers
Oxidative stress (OS) is characterized by an imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify these harmful byproducts through antioxidants. This imbalance is implicated in the aging process and various age-related diseases. Understanding the role of oxidative stress markers in longevity can provide insights into the mechanisms of aging and potential interventions for promoting healthy aging.
- Lower Oxidative Damage in Long-Lived Individuals:
- Long-lived individuals, such as centenarians, exhibit significantly lower oxidative damage to lipids and proteins and lower superoxide anion levels compared to elderly groups. They also show higher activities of certain antioxidants, like glutathione reductase and vitamins A and E, and lower susceptibility to lipid peroxidation.10
- Predictive Markers of Longevity in Immune Cells:
- Certain oxidative and inflammatory stress parameters in immune cells, such as glutathione peroxidase activity and levels of malondialdehyde (MDA), can predict lifespan. These markers vary with age and can reflect adaptive mechanisms underlying high longevity.11
- Oxidative Stress as a Limiting Factor for Longevity:
- Oxidative stress is a major mechanism limiting longevity and healthful aging. Protective mechanisms against oxidative stress, such as increased antioxidant activities, are crucial for extending lifespan and preventing age-related diseases.12,13
- Role of Advanced Lipoxidation and Glycation End Products (ALEs and AGEs):
- The accumulation of ALEs and AGEs due to oxidative stress leads to cellular damage and is implicated in aging and age-related diseases. Maintaining cellular homeostasis and biomolecular stability is crucial for longevity.14
- Environmental Modulation of Oxidative Stress and Longevity:
- Environmental conditions, such as food availability, can modulate the impact of oxidative stress on aging. For instance, challenging environments can alter the levels of oxidative stress markers and improve survival rates.15
- Mitochondrial Dysfunction and Longevity:
- Mitochondrial oxidative stress impairs energy metabolism and reduces stress resistance and longevity. Increased ROS formation and mitochondrial dysfunction are associated with reduced lifespan in model organisms like C. elegans.16
- Oxidative Stress Resistance in Extended Longevity Phenotypes:
- Enhanced oxidative stress resistance and elevated antioxidant defenses are associated with extended longevity in model organisms like Drosophila melanogaster. Lower ROS levels and higher antioxidant activities contribute to longer lifespans.17
- Urinary Markers of Oxidative Stress in Aging:
- Urinary oxidative stress markers, such as 8-OHdG and MDA, vary with age and can be used to monitor health and lifespan in long-lived organisms.
- These markers are helpful for studying the role of oxidative stress in aging under field conditions.18
The collective evidence suggests that lower oxidative damage, higher antioxidant activities, and resistance to oxidative stress are critical factors associated with increased longevity. Environmental conditions and mitochondrial function also significantly modulate oxidative stress and lifespan. Understanding these mechanisms can help develop strategies to promote healthy aging and extend lifespan.
The Role of Lifestyle in Modulating Biomarkers
A focus on these biomarkers allows us to implement specific lifestyle changes that promote longevity:
1. Healthy Diet
Diets rich in fruits, vegetables, whole grains, and lean proteins support longevity by positively impacting telomere length, reducing inflammation, and improving metabolic health. The Mediterranean diet is particularly noted for its benefits on health span.19
2. Regular Exercise
Physical activity can positively influence cardiovascular health, inflammatory markers, metabolic function, and epigenetic age. Both aerobic and strength-training exercises are beneficial in slowing the aging process.
In terms of aerobic fitness, VO2max is a strong, independent predictor of longevity, with higher levels extending life expectancy significantly.20,21Studies consistently show that higher VO2max levels are associated with lower all-cause mortality rates, a 1 mL/min*kg increase in VO2max is linked to a 9% reduction in the risk of all-cause mortality.22 Maintaining or improving VO2max over time is crucial for reducing mortality risk. Long-term decreases in VO2max are associated with increased mortality. 20,21
Engaging in strength-promoting exercises (SPE) is associated with a lower risk of all-cause mortality. Adhering to strength exercise guidelines (≥2 sessions/week) significantly reduces mortality risk.23,24,25,26 Higher levels of muscular strength, as measured by handgrip and knee extension strength tests, are linked to a reduced risk of all-cause mortality. 27,28,29,30 Combining muscle-strengthening activities with aerobic exercises results in a more significant reduction in all-cause mortality compared to either type of exercise alone. 23,25,29
3. Stress Management
Chronic stress increases inflammation and telomere shortening, accelerating aging. Mindfulness, meditation, and adequate sleep can help reduce stress and promote healthier aging.
4. Avoiding Harmful Substances
Smoking, excessive alcohol, and exposure to toxins can harm biomarkers, increasing inflammation and oxidative stress. Reducing or eliminating these exposures supports long-term health.
5. Supplements and Medications
Supplements like vitamin D and antioxidants have shown potential in supporting healthy biomarkers while emerging research suggests drugs like metformin and rapamycin may play a role in healthy aging.
Future Directions in Longevity Research
Aging research is advancing rapidly, uncovering new biomarkers and interventions. The future of anti-aging strategies looks promising, with biotechnologies like gene editing and regenerative medicine offering further extensions to our health span. Personalized medicine, which tailors interventions based on individual biomarker profiles, could soon make targeted anti-aging strategies more accessible and practical, giving us hope for a healthier and longer life.
Conclusion
While immortality remains elusive, understanding and leveraging longevity biomarkers can guide us toward healthier aging. By focusing on biomarkers like telomere length, epigenetic clocks, and inflammation levels, we can implement lifestyle changes that enhance both lifespan and quality of life. Emerging research and technologies continue to offer hope for aging with more excellent health and independence.
Want to learn what your biomarkers are? Contact us today!
References:
- Lassale, C., Batty, G., Steptoe, A., Cadar, D., Akbaraly, T., Kivimäki, M., & Zaninotto, P. (2018). Association of 10-Year C-Reactive Protein Trajectories With Markers of Healthy Aging: Findings From the English Longitudinal Study of Aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 74, 195 - 203. https://doi.org/10.1093/gerona/gly028
- Danesh, J., Wheeler, J., Hirschfield, G., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G., Pepys, M., & Gudnason, V. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.. The New England journal of medicine, 350(14), 1387-97. https://doi.org/10.1056/NEJMOA032804
- Hirano, T. (2021). IL-6 inflammation, autoimmunity, and cancer. International Immunology, 33(3), 127–148, https://doi.org/10.1093/intimm/dxaa078
- Grebenciucova, E., & VanHaerents, S. (2023). Interleukin 6: At the interface of human health and disease. Frontiers in Immunology, 14, 1255533. https://doi.org/10.3389/fimmu.2023.1255533
- Dong, Y., Dekens, D. W., De Deyn, P. P., Naudé, P. J., & Eisel, U. L. (2015). Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders. Antibodies, 4(4), 369-408. https://doi.org/10.3390/antib4040369
- Yi, S., Park, S., Lee, Y., Balkau, B., & Yi, J. (2018). Fasting Glucose and All-Cause Mortality by Age in Diabetes: A Prospective Cohort Study. Diabetes Care, 41, 623 - 626. https://doi.org/10.2337/dc17-1872
- Wang, R., Yu, X., Wang, Z., Liu, Y., Chen, H., Liu, S., Xu, C., Chen, Y., Ge, X., Xia, D., Chang, R., Xu, G., Xiang, M., Wang, Y., Shen, T., Hu, F., & Cai, Y. (2022). Blood lipid levels and all-cause mortality in older adults: the Chinese Longitudinal Healthy Longevity Survey 2008-2018. Epidemiology and Health, 44. https://doi.org/10.4178/epih.e2022054
- Yi, S., Park, H., Jung, M., Yi, J., & Ohrr, H. (2021). High-density lipoprotein cholesterol and cardiovascular mortality: a prospective cohort study among 15.8 million adults. European Journal of Preventive Cardiology, 29(5), 844-854. https://doi.org/10.1093/eurjpc/zwab230
- Pencina, K., Thanassoulis, G., Wilkins, J., Vasan, R., Navar, A., Peterson, E., Pencina, M., & Sniderman, A. (2019). Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.. Journal of the American College of Cardiology, 74(1), 70-79. https://doi.org/10.1016/j.jacc.2019.04.047
- Belenguer-Varea, A., Tarazona-Santabalbina, F., Avellana-Zaragoza, J., Inglés, M., Mas-Bargues, C., & Martínez-Reig, M. (2020). Oxidative stress and exceptional human longevity: Systematic review. Free Radical Biology & Medicine, 149. 51-63. https://doi.org/10.1016/j.freeradbiomed.2019.09.019
- Toda, I., Vida, C., Miguel, L., & Fuente, M. (2019). Function, Oxidative, and Inflammatory Stress Parameters in Immune Cells as Predictive Markers of Lifespan throughout Aging. Oxidative Medicine and Cellular Longevity, 4574276. https://doi.org/10.1155/2019/4574276
- Vatner, S., Zhang, J., Oydanich, M., Berkman, T., Naftalovich, R., & Vatner, D. (2020). Healthful aging mediated by inhibition of oxidative stress. Ageing Research Reviews, 64. https://doi.org/10.1016/j.arr.2020.101194
- Tan, B., Norhaizan, M., Liew, W., & Rahman, H. (2018). Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases. Frontiers in Pharmacology, 9. https://doi.org/10.3389/fphar.2018.01162
- Moldogazieva, N., Mokhosoev, I., Mel'nikova, T., Porozov, Y., & Terentiev, A. (2019). Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases. Oxidative Medicine and Cellular Longevity, 2019. https://doi.org/10.1155/2019/3085756
- Marasco, V., Stier, A., Boner, W., Griffiths, K., Heidinger, B., & Monaghan, P. (2017). Environmental conditions can modulate the links among oxidative stress, age, and longevity. Mechanisms of Ageing and Development, 164, 100-107. https://doi.org/10.1016/j.mad.2017.04.012
- Dilberger, B., Baumanns, S., Schmitt, F., Schmiedl, T., Hardt, M., Wenzel, U., & Eckert, G. (2019). Mitochondrial Oxidative Stress Impairs Energy Metabolism and Reduces Stress Resistance and Longevity of C. elegans. Oxidative Medicine and Cellular Longevity, 2019. https://doi.org/10.1155/2019/6840540
- Deepashree, S., Deepashree, S., Niveditha, S., Shivanandappa, T., & Ramesh, S. (2019). Oxidative stress resistance as a factor in aging: evidence from an extended longevity phenotype of Drosophila melanogaster. Biogerontology, 20, 497 - 513. https://doi.org/10.1007/s10522-019-09812-7
- Thompson, N., Otali, E., Machanda, Z., Muller, M., Wrangham, R., & Emery-Thompson, M. (2019). URINARY MARKERS OF OXIDATIVE STRESS CORRESPOND TO INFECTION AND AGING IN WILD CHIMPANZEES. Innovation in Aging, 3, S896 - S896. https://doi.org/10.1093/geroni/igz038.3275
- Martínez-González, M., Gea, A., & Ruíz-Canela, M. (2019). The Mediterranean Diet and Cardiovascular Health: A Critical Review. Circulation Research, 124, 779–798. https://doi.org/10.1161/CIRCRESAHA.118.313348
- Strasser, B., & Burtscher, M. (2018). Survival of the fittest: VO2max, a key predictor of longevity? Frontiers in bioscience, 23, 1505-1516. https://doi.org/10.2741/4657
- Clausen, J., Marott, J., Holtermann, A., Gyntelberg, F., & Jensen, M. (2018). Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up. Journal of the American College of Cardiology, 72(9), 987-995. https://doi.org/10.1016/j.jacc.2018.06.045
- Laukkanen, J., Zaccardi, F., Khan, H., Kurl, S., Jae, S., & Rauramaa, R. (2016). Long-term Change in Cardiorespiratory Fitness and All-Cause Mortality: A Population-Based Follow-up Study. Mayo Clinic Proceedings, 91(9), 1183-8. https://doi.org/10.1016/j.mayocp.2016.05.014
- Stamatakis, E., Lee, I., Bennie, J., Freeston, J., Hamer, M., O’Donovan, G., Ding, D., Bauman, A., & Mavros, Y. (2018). Does Strength‐Promoting Exercise Confer Unique Health Benefits? A Pooled Analysis of Data on 11 Population Cohorts With All‐Cause, Cancer, and Cardiovascular Mortality Endpoints. American Journal of Epidemiology, 187, 1102–1112. https://doi.org/10.1093/aje/kwx345
- Kraschnewski, J., Sciamanna, C., Poger, J., Rovniak, L., Lehman, E., Cooper, A., Ballentine, N., & Ciccolo, J. (2016). Is strength training associated with mortality benefits? A 15year cohort study of US older adults. Preventive Medicine, 87, 121-127. https://doi.org/10.1016/j.ypmed.2016.02.038
- Momma, H., Kawakami, R., Honda, T., & Sawada, S. (2022). Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. British Journal of Sports Medicine, 56, 755 - 763. https://doi.org/10.1136/bjsports-2021-105061
- Kamada, M., Shiroma, E., Buring, J., Miyachi, M., & Lee, I. (2017). Strength Training and All‐Cause, Cardiovascular Disease, and Cancer Mortality in Older Women: A Cohort Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6. https://doi.org/10.1161/JAHA.117.007677
- García-Hermoso, A., Cavero-Redondo, I., Ramírez‐Vélez, R., Ruiz, J., Ortega, F., Lee, D., & Martínez-Vizcaíno, V. (2018). Muscular Strength as a Predictor of All-Cause Mortality in an Apparently Healthy Population: A Systematic Review and Meta-Analysis of Data From Approximately 2 Million Men and Women.. Archives of physical medicine and rehabilitation, 99(10), 2100-2113.e5. https://doi.org/10.1016/j.apmr.2018.01.008
- Dankel, S., Loenneke, J., & Loprinzi, P. (2016). Determining the Importance of Meeting Muscle-Strengthening Activity Guidelines: Is the Behavior or the Outcome of the Behavior (Strength) a More Important Determinant of All-Cause Mortality? Mayo Clinic Proceedings, 91(2), 166-74. https://doi.org/10.1016/j.mayocp.2015.10.017
- Saeidifard, F., Medina-Inojosa, J., West, C., Olson, T., Somers, V., Bonikowske, A., Prokop, L., Vinciguerra, M., & Lopez‐Jimenez, F. (2019). The association of resistance training with mortality: A systematic review and meta-analysis. European Journal of Preventive Cardiology, 26, 1647 - 1665. https://doi.org/10.1177/2047487319850718
- Jochem, C., Leitzmann, M., Volaklis, K., Aune, D., & Strasser, B. (2019). Association Between Muscular Strength and Mortality in Clinical Populations: A Systematic Review and Meta-Analysis.. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2019.05.015
Jon Esposito, PhD, CSCS, CISSN, USAW